HemostasisCME.org

Back to Previous Page

Unexpected Bleeding Diatheses: Diagnosis and Management

Release Date: February 7, 2008

Expiration Date: February 6, 2009

Estimated time to complete this Activity: 2 hours

---

Overview

The high mortality associated with acquired inhibitors, such as with acquired hemophilia, may be partly related to the delay in recognition and timely treatment of this abnormality. Because the causes of unexpected bleeding in unchallenged patients are numerous, hematologists should be familiar with the laboratory assays and interpretation of their results to distinguish among the different diagnoses and to recommend treatment options. This symposium will use case presentations to raise awareness and improve recognition and understanding among health care professionals regarding some of the most challenging causes of unexpected bleeding including acquired hemophilia.

Target Audience

This CME activity is intended for hematologists, oncologists, and other health care professionals who need further education on identifying and treating patients with acquired hemophilia.

Educational Objectives

After completing this continuing medical education (CME) activity, participants should be able to:

• Describe appropriate laboratory assays that may be used to differentiate acquired hemophilia from other bleeding disorders
• Evaluate the treatment options for bleeding related to acquired hemophilia
• Evaluate the available strategies for eradication of autoantibodies in acquired hemophilia

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The FCG Institute for Continuing Education and Acumentis. The FCG Institute for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The FCG Institute for Continuing Education designates this educational activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physicians who applied for credit for attending the live workshop version of this program may not claim credit for participating in the webcast.

How to Get Credit

To receive CME Credit, you should read the continuing education information then view and participate in the webcast. Your answers from the posttest will be tallied and a passing score of 70% or higher must be attained to receive credit. You must also complete the online evaluation and credit request form. Then print your certificate online. That's it - no need to wait for the certificate to be mailed to you!

Faculty Disclosure

It is the policy of the FCG Institute for Continuing Education that all faculty participating in continuing medical education activities are expected to disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and (2) discussion of unlabeled or unapproved uses of drugs or medical devices. Faculty disclosure statements can be found with their biographical sketches.

The following staff members from both The FCG Institute for Continuing Education and Acumentis who have worked together with the faculty on this educational activity have no financial relationships or affiliations to disclose.

• J. Palmer, PhD
• A. Hosangadi, MS
• L. Ermentrout, BS
• J. Kelly, BS

Conflict of Interest Resolution

When individuals in a position to control or influence the development of the content have reported Financial Relationships with one or more commercial interests, The FCG Institute for Continuing Education utilizes a process to identify and resolve potential conflicts to ensure that the content presented is free of commercial bias. The content of this presentation was vetted through The Institute's process of peer review and content validation and modified as required to meet this standard.

Notice About Investigational or Off-Label Use

This educational activity may include discussion of drugs or devices or uses of drugs and devices that have not been approved by the FDA or have been approved by the FDA for specific uses only. It is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. The FCG Institute for Continuing Education is committed to the free exchange of medical education. Inclusion of any product or device discussion, including discussion of investigational or off-label uses, does not imply endorsement by The Institute of the uses, products, or techniques presented.

Disclaimer

This CME/CE activity is designed for use by healthcare professionals for educational purposes only. The information and opinions expressed by the faculty are their own and do not necessarily reflect those of The FCG Institute. The FCG Institute for Continuing Education does not define a standard of care, nor does it intend to dictate an exclusive course of management but presents through the educational activities it sponsors recognized methods and techniques of clinical practice for consideration by physicians and other healthcare providers for incorporation into their practices. Participants should use their own clinical judgment before applying information, whether provided here or by others, for any professional use.

Back to Top

Check the box to verify that you have read and accept the CE Information and Terms above. Once checked, the page will reload and present links to the content.

Sponsored by: The FCG Institute for Continuing Education

The FCG Institute for Continuing Education
gratefully acknowledges an educational grant from
Novo Nordisk Inc. in support of this Web Site